Machatha Stephen
Aldeyra Therapeutics, Inc. · Chief Development Officer
Machatha Stephen is listed in filings as Chief Development Officer at Aldeyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 13, 2025, including sale activity. Recent filings connect the profile to Aldeyra Therapeutics, Inc. (ALDX). The current snapshot covers public activity from Aug 14, 2024 to Aug 13, 2025. Reported amounts are shown as $113.7K to $76.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $76k16k shares | SellAug 12, 2024 | $4.74 | $1.75 |